Using
sofosbuvir - ledipasvir, which is sold as Harvoni, and is one several new drugs for hepatitis C, researchers compared the
costs of treating patients at all stages of fibrosis, zero through four, with the
cost of waiting until stages three or four, which is when some patients are usually treated.